128 related articles for article (PubMed ID: 23176751)
1. Focused library development of 2-phenylacrylamides as broad spectrum cytotoxic agents.
Tarleton M; Dyson L; Gilbert J; Sakoff JA; McCluskey A
Bioorg Med Chem; 2013 Jan; 21(1):333-47. PubMed ID: 23176751
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic 2-phenyacrylnitriles, the importance of the cyanide moiety and discovery of potent broad spectrum cytotoxic agents.
Tarleton M; Gilbert J; Sakoff JA; McCluskey A
Eur J Med Chem; 2012 Nov; 57():65-73. PubMed ID: 23047225
[TBL] [Abstract][Full Text] [Related]
3. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G
J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890
[TBL] [Abstract][Full Text] [Related]
4. Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro.
Baker JR; Gilbert J; Paula S; Zhu X; Sakoff JA; McCluskey A
ChemMedChem; 2018 Jul; 13(14):1447-1458. PubMed ID: 29771007
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles.
Saczewski F; Reszka P; Gdaniec M; Grünert R; Bednarski PJ
J Med Chem; 2004 Jun; 47(13):3438-49. PubMed ID: 15189040
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity.
Li X; Liu JL; Yang XH; Lu X; Zhao TT; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jul; 20(14):4430-6. PubMed ID: 22705022
[TBL] [Abstract][Full Text] [Related]
7. Development of second-generation indole-based dynamin GTPase inhibitors.
Gordon CP; Venn-Brown B; Robertson MJ; Young KA; Chau N; Mariana A; Whiting A; Chircop M; Robinson PJ; McCluskey A
J Med Chem; 2013 Jan; 56(1):46-59. PubMed ID: 23167654
[TBL] [Abstract][Full Text] [Related]
8. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
9. Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents.
Chen Y; Liu HR; Liu HS; Cheng M; Xia P; Qian K; Wu PC; Lai CY; Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
Eur J Med Chem; 2012 Mar; 49():74-85. PubMed ID: 22265685
[TBL] [Abstract][Full Text] [Related]
10. Quinolone-1-(2H)-ones as hedgehog signalling pathway inhibitors.
Trinh TN; McLaughlin EA; Abdel-Hamid MK; Gordon CP; Bernstein IR; Pye V; Cossar P; Sakoff JA; McCluskey A
Org Biomol Chem; 2016 Jul; 14(26):6304-15. PubMed ID: 27272335
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
[TBL] [Abstract][Full Text] [Related]
12. Microwave-assisted synthesis of 2(1H)-pyridones and their glucosides as cell proliferation inhibitors.
Al-Neyadi SS; Hassan AH; Abdou IM
Nucleosides Nucleotides Nucleic Acids; 2011 Feb; 30(2):120-34. PubMed ID: 21360410
[TBL] [Abstract][Full Text] [Related]
13. Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffold.
Valdenaire A; Pothier J; Renneberg D; Riederer MA; Peter O; Leroy X; Gnerre C; Fretz H
Bioorg Med Chem Lett; 2013 Feb; 23(4):944-8. PubMed ID: 23324405
[TBL] [Abstract][Full Text] [Related]
14. N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.
Wang H; Yu N; Song H; Chen D; Zou Y; Deng W; Lye PL; Chang J; Ng M; Sun ET; Sangthongpitag K; Wang X; Wu X; Khng HH; Fang L; Goh SK; Ong WC; Bonday Z; Stünkel W; Poulsen A; Entzeroth M
Bioorg Med Chem Lett; 2009 Mar; 19(5):1403-8. PubMed ID: 19181524
[TBL] [Abstract][Full Text] [Related]
15. Anti-breast cancer activity of some novel quinoline derivatives.
Ghorab MM; Alsaid MS
Acta Pharm; 2015 Sep; 65(3):271-83. PubMed ID: 26431105
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity of focused compound libraries from the natural product lead, oroidin.
Dyson L; Wright AD; Young KA; Sakoff JA; McCluskey A
Bioorg Med Chem; 2014 Mar; 22(5):1690-9. PubMed ID: 24508308
[TBL] [Abstract][Full Text] [Related]
18. (S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activity.
L'Heureux A; Martel A; He H; Chen J; Sun LQ; Starrett JE; Natale J; Dworetzky SI; Knox RJ; Harden DG; Weaver D; Thompson MW; Wu YJ
Bioorg Med Chem Lett; 2005 Jan; 15(2):363-6. PubMed ID: 15603955
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
Chen Z; Cao R; Shi B; Guo L; Sun J; Ma Q; Fan W; Song H
Eur J Med Chem; 2011 Oct; 46(10):5127-37. PubMed ID: 21875764
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and KCNQ2 opener activity of N-(1-benzo[1,3]dioxol-5-yl-ethyl, N-[1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-[1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamides.
Wu YJ; Sun LQ; He H; Chen J; Starrett JE; Dextraze P; Daris JP; Boissard CG; Pieschl RL; Gribkoff VK; Natale J; Knox RJ; Harden DG; Thompson MW; Fitzpatrick W; Weaver D; Wu D; Gao Q; Dworetzky SI
Bioorg Med Chem Lett; 2004 Sep; 14(17):4533-7. PubMed ID: 15357987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
